Related Experiment Video
Updated: Oct 15, 2025

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
Published on: January 17, 2013
Raynaud Phenomenon and Other Vasospastic Disorders
Ana I Casanegra1, Roger F Shepherd1
1Vascular Medicine Division, Cardiovascular Department, Gonda Vascular Center, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.
Vasospastic disorders, including Raynaud syndrome, affect many people. Treatment varies based on primary or secondary causes to manage symptoms and prevent complications like tissue loss.
Area of Science:
- Vascular Medicine
- Dermatology
- Rheumatology
Background:
- Vasospastic disorders are common, affecting all age groups.
- Primary vasospastic disorders typically present with a benign clinical course.
- Secondary vasospastic disorders are linked to underlying conditions and carry a higher risk of complications.
Purpose of the Study:
- To review the pathophysiology of vasospastic disorders.
- To outline the clinical presentation and diagnostic approaches.
- To discuss management strategies for various vasospastic conditions.
Main Methods:
- Literature review of vasospastic disorders.
- Synthesis of information on pathophysiology, clinical features, diagnosis, and management.
- Focus on Raynaud syndrome, acrocyanosis, livedo reticularis, and pernio.
Main Results:
- Distinction between primary and secondary vasospastic disorders is crucial for prognosis and treatment.
- Complications such as tissue loss and digital ulcerations are more common in secondary forms.
- Effective management hinges on addressing underlying causes in secondary cases and symptom control in primary cases.
Conclusions:
- Understanding the nuances of vasospastic disorders is key for appropriate clinical management.
- Timely diagnosis and tailored treatment can mitigate severe complications.
- This review provides a comprehensive overview for clinicians managing these conditions.
More Related Videos
04:44Author Spotlight: Enhancing Vascular Function and Physical Capacity in Cardiovascular Disease Through Novel Interventions and NIRS Technology
Published on: March 22, 2024
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Vascular Spasm
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Rheumatic Heart Disease I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation